Health
The U.S. has more thalidomide survivors than the government admits
Dr. Frances Oldham Kelsey, then-pharmacologist at the Food and Drug Administration, holds three packages of Contergan, the German brand name for thalidomide, on Oct. 15, 1962.
AI Summary
A 1962 photo shows FDA pharmacologist Frances Oldham Kelsey holding three packages of Contergan, the German brand of thalidomide, before she blocked the drug’s approval for general use in the United States. Recent reporting indicates that the number of U.S. thalidomide survivors is higher than official government estimates. Survivors and advocates are pressing for formal recognition of the larger affected population. The push highlights ongoing concerns about how the drug’s legacy is documented and addressed by federal agencies.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Meal deliveries can save money and improve health. Will they survive Medicaid cuts?Continue reading
- Journalists Discuss What RFK Jr. Recently Told the Anti-Vaccine Group He FoundedContinue reading
- Drones could speed up getting defibrillators to people having cardiac arrests, study suggestsContinue reading
- Research advances understanding of tick-borne Powassan virusContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow